BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6393074)

  • 21. A comparison of cefonicid and cefoxitin for preventing infections after vaginal hysterectomy.
    Mercer LJ; Murphy HJ; Ismail MA; Hajj SN
    J Reprod Med; 1988 Feb; 33(2):223-6. PubMed ID: 3351823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of uncomplicated gonorrhea in women with single-dose cefonicid.
    Handsfield HH; Murphy VL
    Sex Transm Dis; 1985; 12(2):90-2. PubMed ID: 3923633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of urinary tract infections in hospitalized patients: a double-blind comparison of cefonicid and cefamandole.
    Cox CE; Jacob LS
    Rev Infect Dis; 1984; 6 Suppl 4():S839-43. PubMed ID: 6395273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefamandole and cefoxitin.
    Sanders CV; Greenberg RN; Marier RL
    Ann Intern Med; 1985 Jul; 103(1):70-8. PubMed ID: 3890658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parenteral antibiotic therapy at home: experience with intramuscular cefonicid.
    Nadworny HA; Markowitz A
    Clin Ther; 1987; 10(1):82-91. PubMed ID: 3450394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Penetration of cefonicid into human breast milk and various body fluids and tissues.
    Lou MA; Wu YH; Jacob LS; Pitkin DH
    Rev Infect Dis; 1984; 6 Suppl 4():S816-20. PubMed ID: 6522923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative studies of multiple-dose cefoxitin vs. single-dose cefonicid for surgical prophylaxis in patients undergoing biliary tract operations or hysterectomy.
    Maki DG; Lammers JL; Aughey DR
    Rev Infect Dis; 1984; 6 Suppl 4():S887-95. PubMed ID: 6395279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of cefonicid in children.
    Furlanut M; D'Elia R; Riva E; Pasinelli F
    Eur J Clin Pharmacol; 1989; 36(1):79-82. PubMed ID: 2917594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second-generation cephalosporins.
    Glatt AE
    Hosp Pract (Off Ed); 1986 Mar; 21(3):158A-158B, 158E, 158H-158L. PubMed ID: 3081544
    [No Abstract]   [Full Text] [Related]  

  • 30. Single-dose treatment of uncomplicated gonorrhea: a comparison of cefonicid and penicillin.
    Duncan WC; McBride ME
    Rev Infect Dis; 1984; 6 Suppl 4():S875-9. PubMed ID: 6441224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia.
    Wallace RJ; Niefield SL; Waters S; Waters B; Awe RJ; Wiss K; Martin RR; Greenberg SB
    Antimicrob Agents Chemother; 1982 Feb; 21(2):231-5. PubMed ID: 7041813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose treatment of uncomplicated gonococcal urethritis: a comparison of cefonicid and penicillin.
    Duncan WC; McBride ME
    Sex Transm Dis; 1982; 9(2):93-5. PubMed ID: 7101088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefamandole versus cefonicid prophylaxis in cardiovascular surgery: a prospective study.
    Gelfand MS; Simmons BP; Schoettle P; Harrington OB; Martin F; Owen EW; Craft RB; Amarshi N
    Ann Thorac Surg; 1990 Mar; 49(3):435-9. PubMed ID: 2310250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefonicid as therapy for uncomplicated gonococcal urethritis caused by penicillinase-producing Neisseria gonorrhoeae.
    Sanchez PL; Lancaster DJ; Berg SW; Kerbs SB; Harrison WO
    West J Med; 1984 Feb; 140(2):224-6. PubMed ID: 6428048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic antibiotics for elective colorectal surgery or operation for obstruction of the small bowel: a comparison of cefonicid and cefoxitin.
    Fabian TC; Mangiante EC; Boldreghini SJ
    Rev Infect Dis; 1984; 6 Suppl 4():S896-900. PubMed ID: 6395280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefonicid in a once-daily regimen for treatment of osteomyelitis in an ambulatory setting.
    Kunkel MJ; Iannini PB
    Rev Infect Dis; 1984; 6 Suppl 4():S865-9. PubMed ID: 6441223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
    Barriere SL; Hatheway GJ; Gambertoglio JG; Lin ET; Conte JE
    Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefuroxime: mechanisms of action, antimicrobial activity, pharmacokinetics, clinical applications, adverse reactions and therapeutic indications.
    Gold B; Rodriguez WJ
    Pharmacotherapy; 1983; 3(2 Pt 1):82-100. PubMed ID: 6344037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylaxis against infection. Single-dose cefonicid compared with multiple-dose cefamandole.
    Garcia S; Lozano ML; Gatell JM; Soriano E; Ramon R; Sanmiguel JG
    J Bone Joint Surg Am; 1991 Aug; 73(7):1044-8. PubMed ID: 1874767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease.
    McCabe RE; Schlossberg D; Donowitz GR; Scheld WM; Zellner SR; Lindenberg LB; Armstrong JH; Ein ME
    Clin Ther; 1989; 11(3):304-14. PubMed ID: 2663160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.